A Look Ahead at the Coming Medtech “School Year”: A Conversation with MDMA’s Mark Leahey
As the calendar turns from summer to fall, there is no shortage of issues important to the medical device industry emerging on all fronts, addressing legislative, regulatory and policy matters. No one is better aware of the state of play of these issues than Mark Leahey, CEO of MDMA. Here Mark touc…
MDMA’s Leahey Updates on Device Tax, Reimbursement & What the White House Says About Medtech
Mark Leahey, CEO and President of MDMA, delivers his “State of the Industry” address on reimbursement, the medical device tax, UnitedHealthcare/Medtronic and a little bit of Presidential Politics.
MDMA’s Leahey Sees Reasons for Concern and Optimism
Mark Leahey of the MDMA explains how a move against patent troll could cut the legs out from Medtech entrepreneurs and VCs dependent upon IP protection.
DT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two years
This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
This episode is sponsored by Medmarc.
The conversation hit upon five areas that have changed over the past two years due to the …
The Other Side: Mark Leahey from the Medical Device Manufacturers Association
Joe Mullings speaks with President & CEO of Medical Device Manufacturers Association, Mark Leahey, about what they are doing in Washington DC to support patients, manufacturers, entrepreneurs and suppliers during the COVID-19 crisis on the latest episode of The Other Side.
The post The Other Side:…
What Do the US Midterms Mean for Medtech?
Key retirements, important changes in leadership, and some surprising new faces. Now that the dust has almost settled, leaving just one Senate run-off and several House seats still to be settled, what does the election’s outcome mean for the medical device industry, both in terms of prospects f…
Live from OCTANe OTS 2023
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTS with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space.
· Welcome to the Eyeluminaries podcast :01
· Review of episode 16 with Stephen McL…
Eyes on Washington: How the latest news is affecting eye care
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey.
Welcome to the Eyeluminaries podcast :02
Review of episode 31 :40
BVI Medical names a new CCO 2:20
GE HealthCare names Jeannette Bankes president and CEO, Patient Care…
Ep 36 - Enjoy a feast of insights from Spencer Stiles(Stryker) Art Collins(Explorer) and Mark Leahey (MDMA)
DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical.
This week we visit with…
Mark Leahey, pres…
Ep 81 - DT Weekly Roadshow: Five critical changes the Medtech industry has experienced over past two years
This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting.
This episode is sponsored by Medmarc.
The conversation hit upon five areas that have changed over the past two years due to the …
Podcast 搜尋引擎
您可以使用我們的網站按人物、地點或主題搜尋3,821,938Podcast 和195,427,062單集。
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
